Nicotinell Mint Spray Buccal (Nicotine)

The nicotine in the spray binds to nicotinic acetylcholine receptors in the lining of the mouth. This activation mimics the brain’s response to tobacco‑derived nicotine, releasing dopamine and other neurotransmitters that lessen withdrawal discomfort and decrease the urge to smoke.

The specific dosing regimen is determined by a qualified health‑care professional based on the individual’s smoking history, dependence level, and treatment goals. The prescriber will advise the number of sprays per day and any step‑down schedule, ensuring safe and effective use.

Safety data for nicotine buccal spray in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit outweighs the risk. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative cessation strategies with their health‑care provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Compared with nicotine patches, the buccal spray offers faster onset of action because nicotine is absorbed directly through the oral mucosa. Unlike gum, it does not require chewing and provides a discreet, mint‑flavored spray. Choice depends on patient preference, convenience, and specific clinical considerations.

Store the spray at ambient temperature, preferably below 25 °C, in its original packaging. Protect it from excessive heat, direct sunlight, and moisture. Keep the container tightly closed when not in use to maintain product stability and prevent accidental exposure.

The spray is applied directly to the buccal mucosa, typically by pressing the nozzle and delivering a measured spray onto the inner cheek. Users should avoid swallowing immediately, allowing the nicotine to absorb through the oral lining for optimal effect. Follow the prescriber’s instructions regarding frequency.

Serious risks include allergic reactions such as rash, swelling, or anaphylaxis, and rare cardiovascular events like significant increases in heart rate or blood pressure. Users should seek immediate medical attention if they experience symptoms of a severe allergic response or unexplained cardiac discomfort.

Individuals under 18 years of age, patients with known hypersensitivity to nicotine or any component of the spray, and those with uncontrolled cardiovascular disease should avoid using this product. Pregnant or breastfeeding women should only use it after consulting a health‑care professional.